The Procter & Gamble Company
PG
$147.67
-$0.29-0.20%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 84.93B | 84.28B | 83.93B | 84.35B | 83.91B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 84.93B | 84.28B | 83.93B | 84.35B | 83.91B |
| Cost of Revenue | 41.42B | 41.05B | 40.58B | 40.77B | 40.52B |
| Gross Profit | 43.51B | 43.23B | 43.35B | 43.58B | 43.39B |
| SG&A Expenses | 21.53B | 21.48B | 21.90B | 22.29B | 22.16B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.95B | 62.54B | 62.49B | 63.05B | 62.68B |
| Operating Income | 21.98B | 21.75B | 21.44B | 21.30B | 21.23B |
| Income Before Tax | 21.06B | 20.17B | 19.52B | 19.45B | 18.10B |
| Income Tax Expenses | 4.20B | 4.10B | 3.93B | 3.88B | 3.69B |
| Earnings from Continuing Operations | 16.86K | 16.06K | 15.58K | 15.57K | 14.41K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -94.00M | -91.00M | -87.00M | -91.00M | -87.00M |
| Net Income | 16.76B | 15.97B | 15.50B | 15.48B | 14.32B |
| EBIT | 21.98B | 21.75B | 21.44B | 21.30B | 21.23B |
| EBITDA | 24.86B | 24.60B | 24.33B | 24.20B | 24.15B |
| EPS Basic | 6.99 | 6.64 | 6.43 | 6.42 | 5.92 |
| Normalized Basic EPS | 5.66 | 5.36 | 5.32 | 5.28 | 5.26 |
| EPS Diluted | 6.85 | 6.51 | 6.30 | 6.28 | 5.80 |
| Normalized Diluted EPS | 5.46 | 5.16 | 5.12 | 5.07 | 5.05 |
| Average Basic Shares Outstanding | 9.44B | 9.45B | 9.47B | 9.48B | 9.49B |
| Average Diluted Shares Outstanding | 9.79B | 9.82B | 9.85B | 9.87B | 9.88B |
| Dividend Per Share | 4.13 | 4.08 | 4.03 | 3.96 | 3.89 |
| Payout Ratio | 59.51% | 61.80% | 63.04% | 62.14% | 66.12% |